MLCI vs ZBH · rev $53.6M vs P/E 23, rev $4.26B
Mount Logan Capital Inc. Common Stock (MLCI) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Mount Logan Capital Inc. Common Stock (MLCI) is a asset management company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported MLCI revenue for 2025-12-31 was $53.6M. Net income was -$60.8M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. MLCI currently screens at market cap $30.8M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
MLCI currently screens at market cap $30.8M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the MLCI and ZBH stock pages for the full models.
Not investment advice.